( en | de | ru )

 

Disambiguation

From post

копироватьудалитьдобавить публикацию в буфер
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.

, , , , , , , , , , и . Cancer Lett, 250 (2): 250--267 (июня 2007)
DOI: 10.1016/j.canlet.2006.10.016

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

Josef Kahlert

Annamarie Kahlert

Holger Kahlert

Margit Kahlert

Steffen Kahlert

 

Другие публикации лиц с тем же именем

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers., , , , , , , , , и 27 other автор(ы). Clin Cancer Res, 21 (8): 1904-1915 (апреля 2015)Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers, , , , , , , , , и 27 other автор(ы). Clinical Cancer Research, (сентября 2014)The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models., , , , , , , , , и 193 other автор(ы). Nat Biotechnol, 28 (8): 827--838 (августа 2010)Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome., , , , , , , , , и . Clin Cancer Res, 12 (17): 5118--5128 (сентября 2006)Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , и 4 other автор(ы). J Clin Oncol, 24 (31): 5070--5078 (ноября 2006)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , и 1 other автор(ы). Cancer Lett, 250 (2): 250--267 (июня 2007)Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR., , , , , , , , и . Clin Cancer Res, 14 (20): 6590--6601 (октября 2008)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma., , , , , , , , , и 8 other автор(ы). Clin Cancer Res, 17 (15): 5082--5092 (августа 2011)